9robes

9robes

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., Docket No. 24-889

5 min · 4. juni 2026
episode Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., Docket No. 24-889 cover

Description

This ruling protects generic drug competition while still holding companies accountable if they cross the line into deliberately promoting patented uses. For patients and consumers, it means generic drugs will remain a competitive force in the market. For brand-name companies, it means they need clear evidence of intentional wrongdoing, not just circumstantial suggestions, to win these lawsuits. music for the podcast provided by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dimitry Taras [https://pixabay.com/music/upbeat-upbeat-energetic-rock-fun-happy-travel-background-254065/]

Comments

0

Be the first to comment

Sign up now and become a member of the 9robes community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

149 episodes